DLB vs XLI
Dolby Laboratories (DLB) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Dolby Laboratories (DLB) is a specialty business services company listed on US.
XLI (XLI) common stock.
Latest reported DLB revenue for 2025-09-26 was $1.35B. Net income was $256.5M. DLB currently screens at market cap $7.19B and trailing P/E 28.3.
XLI does not have a complete income-statement cache yet.
DLB currently screens at market cap $7.19B and trailing P/E 28.3. XLI currently screens at market cap $0.
Not investment advice. Open the DLB and XLI stock pages for the full models.
Not investment advice.